Generation of expandable cardiovascular progenitor cells from mouse and human fibroblasts via direct chemical reprogramming
- PMID: 36595887
- PMCID: PMC9730216
- DOI: 10.1016/j.xpro.2022.101908
Generation of expandable cardiovascular progenitor cells from mouse and human fibroblasts via direct chemical reprogramming
Abstract
Here, we present a protocol to reprogram mouse and human fibroblasts into expandable cardiovascular progenitor cells (CPCs) via a defined small-molecule treatment. We describe steps to prepare fibroblasts and generate the chemically induced CPCs (ciCPCs), followed by expansion and differentiation of the ciCPCs. These cells can self-renew in the long term, faithfully retaining the CPC phenotype and cardiovascular differentiation capacity. This protocol provides an autologous and expandable cardiovascular cell source, which may find uses in cardiovascular disease modelling, drug discovery, and cardiac cell therapy. For complete details on the use and execution of this protocol, please refer to Wang et al. (2022).1.
Keywords: Cell Biology; Cell Differentiation; Cell culture; Cell-based Assays; Stem Cells.
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Figures




Similar articles
-
Reprogramming of fibroblasts into expandable cardiovascular progenitor cells via small molecules in xeno-free conditions.Nat Biomed Eng. 2022 Apr;6(4):403-420. doi: 10.1038/s41551-022-00865-7. Epub 2022 Mar 31. Nat Biomed Eng. 2022. PMID: 35361933
-
CRISPR activation of endogenous genes reprograms fibroblasts into cardiovascular progenitor cells for myocardial infarction therapy.Mol Ther. 2022 Jan 5;30(1):54-74. doi: 10.1016/j.ymthe.2021.10.015. Epub 2021 Oct 20. Mol Ther. 2022. PMID: 34678511 Free PMC article.
-
Expandable hESC-derived cardiovascular progenitor cells generate functional cardiac lineage cells for microtissue construction.Stem Cell Res Ther. 2024 Sep 12;15(1):298. doi: 10.1186/s13287-024-03919-6. Stem Cell Res Ther. 2024. PMID: 39267174 Free PMC article.
-
The Future of Direct Cardiac Reprogramming: Any GMT Cocktail Variety?Int J Mol Sci. 2020 Oct 26;21(21):7950. doi: 10.3390/ijms21217950. Int J Mol Sci. 2020. PMID: 33114756 Free PMC article. Review.
-
Generation of induced cardiac progenitor cells via somatic reprogramming.Oncotarget. 2017 Apr 25;8(17):29442-29457. doi: 10.18632/oncotarget.15272. Oncotarget. 2017. PMID: 28199972 Free PMC article. Review.
Cited by
-
Enhancing Cardiomyocyte Purity through Lactate-Based Metabolic Selection.Tissue Eng Regen Med. 2025 Feb;22(2):249-260. doi: 10.1007/s13770-024-00696-4. Epub 2025 Jan 17. Tissue Eng Regen Med. 2025. PMID: 39820961
-
Reprogramming of human urine cells into cardiomyocytes via a small molecule cocktail in xeno-free conditions.Commun Med (Lond). 2025 Jul 1;5(1):266. doi: 10.1038/s43856-025-00963-y. Commun Med (Lond). 2025. PMID: 40595290 Free PMC article.
References
-
- Wang J., Gu S., Liu F., Chen Z., Xu H., Liu Z., Cheng W., Wu L., Xu T., Chen Z., et al. Reprogramming of fibroblasts into expandable cardiovascular progenitor cells via small molecules in xeno-free conditions. Nat. Biomed. Eng. 2022;6:403–420. - PubMed
-
- Qyang Y., Martin-Puig S., Chiravuri M., Chen S., Xu H., Bu L., Jiang X., Lin L., Granger A., Moretti A., et al. The renewal and differentiation of Isl1+ cardiovascular progenitors are controlled by a Wnt/beta-catenin pathway. Cell Stem Cell. 2007;1:165–179. - PubMed
-
- Menasché P., Vanneaux V., Hagège A., Bel A., Cholley B., Cacciapuoti I., Parouchev A., Benhamouda N., Tachdjian G., Tosca L., et al. Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report. Eur. Heart J. 2015;36:2011–2017. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources